Glaukos : Investor Presentation May 2024
Investor Presentation May 2024 Disclaimer ...
Stay updated with breaking news from Investor Section. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investor Presentation May 2024 Disclaimer ...
ALB earnings call for the period ending March 31, 2024.
Meredith Bandy: Thank you. Welcome everyone to Albemarle's first quarter 2024 earnings conference call.
Glaukos Corporation , an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced...
Glaukos Corporation , an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today...